Cisatracurium Besylate Injection
Product Images NDC 65145-135

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 65145-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cisatracurium-besylate-carton-10ml (Cisatracurium Besylate Carton 10ml)

Label for Cisatracurium Besylate Injection, USP 20 mg/10 mL (2 mg/mL) intravenous injection. The 10 mL multiple-dose vial label includes warnings of it being a paralyzing agent and contains 0.9% benzyl alcohol as a preservative. Manufacturer is Caplin Steriles Limited, India. Storage instructions and barcode are also shown.*

FDA Label Image

Cisatracurium-besylate-carton-20ml (Cisatracurium Besylate Carton 20ml)

Packaging label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL) intravenous injection by Caplin Steriles Limited. The label highlights it as a preservative-free, single-dose vial for ICU use only with warnings about its paralyzing effects and the need for artificial respiration facilities. Storage instructions and manufacturer details are included.*

FDA Label Image

Cisatracurium-besylate-carton-5ml (Cisatracurium Besylate Carton 5ml)

Label for Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) by Caplin Steriles Limited. It includes warnings about paralysis and respiratory arrest, states it is preservative free, for intravenous use in a 5 mL single-dose vial, and lists storage instructions. The label also displays the NDC 65145-135-01 and a barcode.*

FDA Label Image

Fig-1 (Cisatracurium Besylate Figure 1)

A scatter plot with percent change on both axes, showing data points clustered near the center. The vertical axis is labeled 'HR' with a range from -60% to +60%, and the horizontal axis is labeled 'MAP' with a similar range. The plot visualizes variability or correlation between heart rate (HR) and mean arterial pressure (MAP).*

FDA Label Image

Fig-2 (Cisatracurium Besylate Figure 2)

A scatter plot depicting the relationship between heart rate (HR) and mean arterial pressure (MAP) percentage changes, ranging from -60% to +60% on both axes. Several black dots are clustered near the center, indicating data points around no change in HR and MAP.*

FDA Label Image

Cisatracurium-besylate-sticker-label (Cisatracurium Besylate Sticker Label)

Label for Cisatracurium Besylate Injection, USP. The label prominently displays a warning stating the drug is a paralyzing agent that causes respiratory arrest. A blank space is provided for indicating the concentration in mg/mL. The label has a red background with white text.*

FDA Label Image

Str (Cisatracurium Besylate Structure)

Chemical structure diagram of Cisatracurium besylate showing its molecular components with detailed arrangements of atoms and bonds including multiple methoxy groups and benzene rings.*

FDA Label Image

Cisatracurium-besylate-vial-10ml (Cisatracurium Besylate Vial 10ml)

Label for Cisatracurium Besylate Injection USP, 2 mg/mL (20 mg/10 mL) in a 10 mL multiple-dose vial. It is indicated for intravenous injection and contains 0.9% benzyl alcohol as a preservative. The label includes a warning about the drug's paralytic effects and storage instructions. Manufactured by Caplin Steriles Limited, India.*

FDA Label Image

Cisatracurium-besylate-vial-20ml (Cisatracurium Besylate Vial 20ml)

Label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL), a paralyzing agent indicated for ICU use. It is for intravenous injection in a 20 mL single-dose vial, labeled with warnings about respiratory arrest and instructions for storage at 2° to 8°C. Manufactured by Caplin Steriles Limited, India.*

FDA Label Image

Cisatracurium-besylate-vial-5ml (Cisatracurium Besylate Vial 5ml)

Label for Cisatracurium Besylate Injection, USP, 10 mg/5 mL (2 mg/mL) preservative-free intravenous injection. The label includes a warning that it is a paralyzing agent causing respiratory arrest and must be used where artificial respiration is immediately available. It is a 5 mL single-dose vial manufactured by Caplin Steriles Limited, India, with storage instructions to keep refrigerated between 2° to 8°C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.